{"id":"intensified-chemotherapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, anemia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Cardiotoxicity (doxorubicin-related)"},{"rate":null,"effect":"Nephrotoxicity (cisplatin-related)"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Alopecia"}]},"_chembl":{"chemblId":"CHEMBL4297950","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach involves escalating standard chemotherapy regimens—typically multi-agent combinations such as doxorubicin, cisplatin, and ifosfamide—to achieve greater cytotoxic effect against sarcoma cells. The intensification strategy aims to improve disease control and survival outcomes, particularly in high-risk or advanced sarcoma cases, by pushing tolerability limits while managing supportive care.","oneSentence":"Intensified chemotherapy uses higher doses or more aggressive combinations of cytotoxic agents to maximize tumor cell kill in sarcoma patients.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:22.755Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"High-risk or metastatic soft tissue sarcoma"},{"name":"Osteosarcoma"}]},"trialDetails":[{"nctId":"NCT06112418","phase":"NA","title":"A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events","status":"RECRUITING","sponsor":"Cleerly, Inc.","startDate":"2024-03-06","conditions":"Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome","enrollment":7500},{"nctId":"NCT03952585","phase":"PHASE2, PHASE3","title":"De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-09","conditions":"Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":384},{"nctId":"NCT04574856","phase":"PHASE2","title":"Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2020-11-04","conditions":"Glioblastoma","enrollment":30},{"nctId":"NCT03875716","phase":"NA","title":"Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2019-05-20","conditions":"Head and Neck Cancer","enrollment":111},{"nctId":"NCT04502407","phase":"PHASE2","title":"Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2021-02-16","conditions":"HPV Positive Oropharyngeal Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT00208260","phase":"PHASE2, PHASE3","title":"Intensified Chemotherapy in CRC After Resection of Liver Metastases","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2004-04","conditions":"Colorectal Cancer, Liver Metastases, Chemotherapy","enrollment":124},{"nctId":"NCT07375563","phase":"PHASE3","title":"Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2025-11-19","conditions":"Neuroblastoma (NB), Ganglioneuroblastoma","enrollment":5},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT01871766","phase":"PHASE2","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-12-04","conditions":"Rhabdomyosarcoma","enrollment":115},{"nctId":"NCT02881086","phase":"PHASE3","title":"Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment","status":"COMPLETED","sponsor":"Goethe University","startDate":"2016-08","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":1023},{"nctId":"NCT04580446","phase":"PHASE1","title":"HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-03","conditions":"Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer","enrollment":24},{"nctId":"NCT02810743","phase":"PHASE3","title":"Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-01-25","conditions":"Breast Cancer","enrollment":174},{"nctId":"NCT03011528","phase":"PHASE2","title":"First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)","status":"COMPLETED","sponsor":"Institut Curie","startDate":"2016-12","conditions":"Ewing Sarcoma Family of Tumors","enrollment":45},{"nctId":"NCT03805022","phase":"PHASE3","title":"Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas","status":"RECRUITING","sponsor":"Institut Bergonié","startDate":"2019-02-14","conditions":"Non-metastatic Soft-tissue Sarcoma, Resectable","enrollment":351},{"nctId":"NCT05973851","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2024-08-31","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":418},{"nctId":"NCT05973786","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-02-11","conditions":"Bipolar Depression","enrollment":418},{"nctId":"NCT05958875","phase":"PHASE4","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2024-08-01","conditions":"Schizophrenia and Related Disorders, Early Treatment-Resistance","enrollment":418},{"nctId":"NCT07104604","phase":"PHASE1","title":"Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement","status":"RECRUITING","sponsor":"Affiliated Cancer Hospital of Shantou University Medical College","startDate":"2025-08-01","conditions":"Rectal Cancer","enrollment":59},{"nctId":"NCT04907370","phase":"PHASE3","title":"PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-08-01","conditions":"Nasopharyngeal Carcinoma","enrollment":532},{"nctId":"NCT04861558","phase":"PHASE3","title":"Efficacy of Hyperthermic Intraperitoneal Chemotherapy","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2021-05-01","conditions":"Colorectal Cancer, Peritoneal Metastases","enrollment":213},{"nctId":"NCT04478292","phase":"PHASE3","title":"A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy","status":"RECRUITING","sponsor":"Shanghai Children's Medical Center","startDate":"2021-03-01","conditions":"Hepatoblastoma","enrollment":330},{"nctId":"NCT03107182","phase":"PHASE2","title":"Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2017-06-27","conditions":"HPV-Related Squamous Cell Carcinoma, HNSCC","enrollment":72},{"nctId":"NCT06894459","phase":"PHASE2","title":"A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2025-05-08","conditions":"Head and Neck Cancers","enrollment":180},{"nctId":"NCT00408005","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-01-30","conditions":"T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma","enrollment":1895},{"nctId":"NCT03643276","phase":"PHASE3","title":"Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017","status":"RECRUITING","sponsor":"Martin Schrappe","startDate":"2018-07-15","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":5000},{"nctId":"NCT04296175","phase":"PHASE3","title":"Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fudan University","startDate":"2020-03-05","conditions":"Triple-negative Breast Cancer","enrollment":808},{"nctId":"NCT04043494","phase":"PHASE3","title":"International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma","status":"RECRUITING","sponsor":"University Hospital Muenster","startDate":"2019-08-23","conditions":"Lymphoblastic Lymphoma, Childhood","enrollment":683},{"nctId":"NCT06880289","phase":"PHASE2","title":"Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2020-09-16","conditions":"Squamous Cell Tumors of the Head and Neck","enrollment":91},{"nctId":"NCT04230408","phase":"PHASE2","title":"Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers","status":"COMPLETED","sponsor":"Latin American Cooperative Oncology Group","startDate":"2021-03-05","conditions":"Lung Neoplasms","enrollment":48},{"nctId":"NCT06794710","phase":"NA","title":"Early Identification and Treatment of Rare Cardiomyopathy Cohorts","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-02-01","conditions":"Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy","enrollment":300},{"nctId":"NCT05534087","phase":"PHASE3","title":"Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2022-12-15","conditions":"Colon Cancer","enrollment":236},{"nctId":"NCT05487495","phase":"PHASE1","title":"Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma","status":"WITHDRAWN","sponsor":"Beijing Boren Hospital","startDate":"2022-08-03","conditions":"T-Cell Acute Lymphoblastic Leukemia/Lymphoma","enrollment":""},{"nctId":"NCT05032599","phase":"PHASE1","title":"Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"Beijing Boren Hospital","startDate":"2021-09-14","conditions":"T-Cell Acute Lymphoblastic Leukemia","enrollment":19},{"nctId":"NCT06643962","phase":"NA","title":"Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy","status":"RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2024-10-31","conditions":"Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute","enrollment":83},{"nctId":"NCT04680260","phase":"PHASE2","title":"OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Karen-Lise Garm Spindler","startDate":"2021-10-25","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":350},{"nctId":"NCT02945631","phase":"NA","title":"Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2016-04-25","conditions":"Locally Advanced HPV Positive Oropharynx Cancer","enrollment":43},{"nctId":"NCT03927222","phase":"PHASE2","title":"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","status":"TERMINATED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2019-09-30","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT02684708","phase":"PHASE3","title":"Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Giessen","startDate":"2015-10-01","conditions":"Classical Hodgkin Lymphoma","enrollment":2200},{"nctId":"NCT01497002","phase":"PHASE3","title":"Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a","status":"COMPLETED","sponsor":"University of Leipzig","startDate":"2005-04","conditions":"Acute Myeloid Leukaemia","enrollment":1222},{"nctId":"NCT05944328","phase":"NA","title":"Effectiveness of an Intervention of Pharmacotherapeutic Plans to Reduce Medication-related Problems in Geriatric Residences","status":"UNKNOWN","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2023-02-22","conditions":"Polypharmacy","enrollment":862},{"nctId":"NCT02396043","phase":"PHASE2","title":"Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-03","conditions":"Lymphoma, Lymphoblastic","enrollment":50},{"nctId":"NCT05866146","phase":"NA","title":"Feasibility of an Interprofessional Rehabilitation Program for Chronic Low Back Patients in the Ethiopian Health Setting","status":"UNKNOWN","sponsor":"Queen's University","startDate":"2023-05-20","conditions":"Chronic Low-back Pain","enrollment":40},{"nctId":"NCT03531502","phase":"NA","title":"Initial Management of Patients Receiving a Single Shock (IMPRESS)","status":"TERMINATED","sponsor":"Saint Luke's Health System","startDate":"2018-04-09","conditions":"Ventricular Tachycardia","enrollment":30},{"nctId":"NCT05772208","phase":"PHASE3","title":"Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy","status":"RECRUITING","sponsor":"Fudan University","startDate":"2022-01-01","conditions":"Nasopharyngeal Carcinoma","enrollment":459},{"nctId":"NCT01646034","phase":"PHASE3","title":"High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2014-09","conditions":"Breast Cancer","enrollment":74},{"nctId":"NCT02063022","phase":"PHASE3","title":"Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma","status":"COMPLETED","sponsor":"Italian Sarcoma Group","startDate":"2009-01-22","conditions":"Ewing's Sarcoma","enrollment":278},{"nctId":"NCT01516593","phase":"PHASE2","title":"Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma","status":"COMPLETED","sponsor":"Andres J. M. Ferreri","startDate":"2011-11","conditions":"HIV, Burkitt's Lymphoma","enrollment":19},{"nctId":"NCT02864368","phase":"PHASE1","title":"Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens","status":"TERMINATED","sponsor":"Eric Thompson, M.D.","startDate":"2016-12-07","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":27},{"nctId":"NCT03748680","phase":"PHASE2","title":"IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer","status":"UNKNOWN","sponsor":"Karen-Lise Garm Spindler","startDate":"2018-10-01","conditions":"Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemotherapy","enrollment":64},{"nctId":"NCT01093066","phase":"PHASE2","title":"Prospective Multicentric Evaluation of a Bladder Preservation Strategy","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2010-09-21","conditions":"Urothelial Carcinoma","enrollment":77},{"nctId":"NCT02125136","phase":"PHASE2","title":"Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"AIO-Studien-gGmbH","startDate":"2014-11","conditions":"Ductal Adenocarcinoma of the Pancreas","enrollment":168},{"nctId":"NCT03815487","phase":"NA","title":"Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)","status":"COMPLETED","sponsor":"Kinderkrankenhaus auf der Bult","startDate":"2018-11-19","conditions":"Patient Care, Drug Therapy","enrollment":40},{"nctId":"NCT00103285","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-04-11","conditions":"Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":5377},{"nctId":"NCT00866307","phase":"PHASE1","title":"Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-02-23","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":104},{"nctId":"NCT04815694","phase":"NA","title":"THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy","status":"UNKNOWN","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-03-17","conditions":"Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response","enrollment":63},{"nctId":"NCT02818725","phase":"PHASE3","title":"I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2010-06","conditions":"Infiltrating Urothelial Carcinoma, KRAS Gene Mutation","enrollment":133},{"nctId":"NCT04175899","phase":"NA","title":"Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2019-12-10","conditions":"Solid Tumor, Adult","enrollment":106},{"nctId":"NCT04720144","phase":"","title":"Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2020-10-01","conditions":"Invasive Mold Infections, Breakthrough Invasive Mold Infections, Hematologic Malignancy","enrollment":300},{"nctId":"NCT00448266","phase":"PHASE2, PHASE3","title":"Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD","status":"TERMINATED","sponsor":"The Netherlands Cancer Institute","startDate":"2007-05","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT04715412","phase":"NA","title":"Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2020-03-10","conditions":"Transplant;Failure,Kidney","enrollment":60},{"nctId":"NCT00720109","phase":"PHASE2, PHASE3","title":"Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-07-14","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":63},{"nctId":"NCT00398554","phase":"PHASE2","title":"Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Christine Mauz-Körholz","startDate":"2005-06","conditions":"Lymphoma","enrollment":16},{"nctId":"NCT02042690","phase":"PHASE3","title":"Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients","status":"COMPLETED","sponsor":"Peking University","startDate":"2014-07","conditions":"Acute Lymphoblastic Leukemia","enrollment":131},{"nctId":"NCT01966913","phase":"PHASE1, PHASE2","title":"Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-04","conditions":"Germ Cell Tumor","enrollment":30},{"nctId":"NCT00133991","phase":"PHASE2","title":"Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2005-07","conditions":"Leukemia, Lymphoma","enrollment":23},{"nctId":"NCT01830270","phase":"PHASE2","title":"Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2011-05","conditions":"Stomach Neoplasms, Oesophageal Junction Cancer, Lower Oesophagus Cancer","enrollment":30},{"nctId":"NCT00276640","phase":"NA","title":"Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"2004-04-01","conditions":"Primary Central Nervous System Neoplasms","enrollment":3417},{"nctId":"NCT01492348","phase":"NA","title":"Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2012-01","conditions":"Posttraumatic Stress Disorder (PTSD), Depression","enrollment":666},{"nctId":"NCT02797717","phase":"NA","title":"Treatment for Classical Hodgkin Lymphoma in Children and Adolescents","status":"RECRUITING","sponsor":"GALIA AVRAHAMI","startDate":"2015-11","conditions":"Classical Hodgkins Lymphoma in Children and Adolescents.","enrollment":2200},{"nctId":"NCT00544232","phase":"PHASE3","title":"Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)","status":"COMPLETED","sponsor":"GBG Forschungs GmbH","startDate":"2002-08","conditions":"Breast Cancer","enrollment":720},{"nctId":"NCT00144755","phase":"PHASE3","title":"R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"Lymphoma Study Association","startDate":"2003-12","conditions":"Diffuse Large Cell Lymphoma","enrollment":600},{"nctId":"NCT01424839","phase":"PHASE4","title":"Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors","status":"UNKNOWN","sponsor":"University Hospital Muenster","startDate":"2011-10","conditions":"Intracranial Germ Cell Tumors","enrollment":400},{"nctId":"NCT00005796","phase":"PHASE1","title":"Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors","status":"COMPLETED","sponsor":"Indiana University","startDate":"2000-02","conditions":"Bone Marrow Suppression, Brain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ","enrollment":10},{"nctId":"NCT01517490","phase":"","title":"Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes","status":"UNKNOWN","sponsor":"Glostrup University Hospital, Copenhagen","startDate":"2011-08","conditions":"Diabetes Mellitus, Diabetic Retinopathy","enrollment":100},{"nctId":"NCT00002870","phase":"PHASE3","title":"High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer","status":"COMPLETED","sponsor":"UNICANCER","startDate":"1994-12","conditions":"Breast Cancer","enrollment":180},{"nctId":"NCT00077389","phase":"PHASE2","title":"Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2004-01","conditions":"Liver Cancer","enrollment":57},{"nctId":"NCT01945879","phase":"PHASE1, PHASE2","title":"Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer","status":"COMPLETED","sponsor":"CONKO-Studiengruppe","startDate":"2003-01","conditions":"Pancreatic Cancer","enrollment":19},{"nctId":"NCT00002531","phase":"PHASE2","title":"Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia","status":"UNKNOWN","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"1993-01","conditions":"Leukemia","enrollment":""},{"nctId":"NCT00004089","phase":"PHASE2","title":"Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1999-08","conditions":"Head and Neck Cancer","enrollment":""},{"nctId":"NCT01271322","phase":"PHASE2","title":"Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)","status":"TERMINATED","sponsor":"National Center for Tumor Diseases, Heidelberg","startDate":"2010-10","conditions":"Adenocarcinomas of the Esophagogastric Junction","enrollment":""},{"nctId":"NCT01054781","phase":"PHASE2","title":"Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2009-01","conditions":"Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":91},{"nctId":"NCT00707382","phase":"NA","title":"Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment","status":"COMPLETED","sponsor":"Gesche Jurgens","startDate":"2008-02","conditions":"Schizophrenia","enrollment":311},{"nctId":"NCT01489332","phase":"PHASE2","title":"Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer","status":"UNKNOWN","sponsor":"Institute of Oncology Ljubljana","startDate":"2011-10","conditions":"Rectal Cancer","enrollment":60},{"nctId":"NCT01126866","phase":"PHASE2","title":"Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy","status":"TERMINATED","sponsor":"National Center for Tumor Diseases, Heidelberg","startDate":"2009-06","conditions":"Colorectal Carcinoma","enrollment":35},{"nctId":"NCT00499018","phase":"PHASE3","title":"Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma","status":"UNKNOWN","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2006-01","conditions":"Diffuse Large B-Cell Lymphoma, IPI≥2","enrollment":399},{"nctId":"NCT01212718","phase":"PHASE2","title":"Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2001-07","conditions":"Colorectal Cancer, Non Resectable Metastasis, Reference Lesion","enrollment":168},{"nctId":"NCT00314977","phase":"PHASE3","title":"Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2006-02","conditions":"Breast Cancer","enrollment":200},{"nctId":"NCT00221845","phase":"PHASE3","title":"Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"1998-01","conditions":"Children, Chronic Renal Failure, Hypertension","enrollment":400},{"nctId":"NCT00793377","phase":"PHASE3","title":"Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer","status":"COMPLETED","sponsor":"GBG Forschungs GmbH","startDate":"","conditions":"Primary Breast Cancer","enrollment":913}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":406,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vincristine,","Doxorubicin","Ifosfamide","Cyclophosphamide","Etoposide"],"phase":"phase_3","status":"active","brandName":"Intensified chemotherapy","genericName":"Intensified chemotherapy","companyName":"Italian Sarcoma Group","companyId":"italian-sarcoma-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intensified chemotherapy uses higher doses or more aggressive combinations of cytotoxic agents to maximize tumor cell kill in sarcoma patients. Used for High-risk or metastatic soft tissue sarcoma, Osteosarcoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}